American Association for Cancer Research Conference 2025

Explore miRNA Transcriptomics with BioSpyder at AACR 2025 – Booth 4102 

BioSpyder is excited to announce our participation in the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025, taking place April 24–30 in Chicago, IL. Join us at Booth #4102 to discover the latest innovations in miRNA transcriptomics, next-generation sequencing (NGS) applications, and high-throughput toxicology. 

We’re proud to highlight our newly launched miRNA Whole Transcriptome Assay (miRNA WT) — a cutting-edge solution for researchers looking to perform comprehensive miRNA profiling. This assay offers a scalable and efficient method for detecting human microRNA expression across a wide range of transcripts, making it an ideal platform for cancer research, toxicogenomics, and biomarker discovery. 

Built on BioSpyder’s proven TempO-Seq™ technology, the Whole miRNAome assay provides transcriptome-wide coverage without the complexity of traditional RNA-seq workflows. Whether you're exploring gene expression in microRNA, conducting miRNA panel screening, or developing targeted diagnostics, our platform is designed to support and accelerate your research. 

Let’s talk miRNAs, transcriptomics, and innovation — see you in Chicago. 

About BioSpyder 

BioSpyder is a leading provider of advanced molecular biology technologies, dedicated to advancing scientific research in toxicology, cancer biology, and environmental health. Our TempO-Seq platform and other innovative solutions are transforming genomics research, driving progress in drug discovery, translational research, and diagnostics.